Kestrel

SEL ICB Lambeth Community Denosumab Service

NHS South East London Integrated Care Board · published Wed 29 Jul 2026

In plain English

Reading the notice and writing a summary. This takes a few seconds the first time.

Who holds it now

Last won by SignHealth in Mar 2026.

What you're up against

  • The last two awards went to different firms: this buyer has changed supplier before.
  • 2 different firms won this buyer's 2 awards for this kind of work since 2025.

From NHS South East London Integrated Care Board's earlier award notices for the same kind of work. The tender documents usually say which contract this one replaces.

The notice doesn't say where the documents are, but NHS South East London Integrated Care Board's other tenders use Atamis. Register there (it's free) and look for this tender, or email the buyer's contact on the notice.

The notice as published

Provision of a community-based shared care service for the administration and monitoring of denosumab 60mg/ml for osteoporosis. The service will support patients in Lambeth (or registered with a Lambeth GP) who have been identified by secondary care as clinically appropriate for treatment in the community. The Provider will deliver blood monitoring, prescribing support, and timely administration of injections in accordance with the South East London Shared Care Agreement, while clinical responsibility remains with secondary care.